Biotech · Private company
Autolus Limited
Track this companyFree. Adds Autolus Limited to your Dealase workspace and tells you when its record changes.
Clinical trials86 recruiting or active
Pipeline programs6From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline6
- AUTO CAR T cell therapyPhase 2 · Patients Followed for up to 15 Years Following Their First Dose of AUTO CAR T Cell TherapyClinicalTrials.gov · fetched Nov 12, 2026
- AUTO1Phase 2 · Relapsed or Refractory B Cell Acute Lymphoblastic LeukemiaClinicalTrials.gov · fetched Nov 12, 2026
- AUTO3Phase 2 · Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)ClinicalTrials.gov · fetched Nov 12, 2026
- Obecabtagene autoleucelPhase 2 · Lupus NephritisClinicalTrials.gov · fetched Nov 12, 2026
- Obecabtagene autoleucel (obe-cel)Phase 1 · Progressive Multiple SclerosisClinicalTrials.gov · fetched Nov 12, 2026
- Out-of-specification obecabtagene autoleucelLymphoblastic Leukemia, Acute, AdultClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials8
- A Study of Obecabtagene Autoleucel in People With B-cell Acute Lymphoblastic LeukemiaPHASE2 · RECRUITING · started Feb 3, 2026ClinicalTrials.gov NCT07400029 · fetched Nov 12, 2026
- Obe-cel in Severe, Refractory Systemic Lupus Erythematosus (SLE) With Active Lupus Nephritis (LN)PHASE2 · RECRUITING · started Jan 16, 2026ClinicalTrials.gov NCT07053800 · fetched Nov 12, 2026
- Obe-cel in Refractory Progressive Forms of Multiple SclerosisPHASE1 · RECRUITING · started Aug 4, 2025ClinicalTrials.gov NCT07139743 · fetched Nov 12, 2026
- A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)PHASE1 · RECRUITING · started Nov 16, 2023ClinicalTrials.gov NCT06173518 · fetched Nov 12, 2026
- A Study of CD19 Targeted CAR T Cell Therapy in Adult Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukaemia (ALL)PHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started Jun 3, 2020ClinicalTrials.gov NCT04404660 · fetched Nov 12, 2026
- Long-term Follow-up of Patients Treated With Genetically Modified Autologous T CellsPHASE2 · ENROLLING_BY_INVITATION · started Aug 2, 2018ClinicalTrials.gov NCT03628612 · fetched Nov 12, 2026
- Cluster of Differentiation Antigen 19/22(CD19/22) CAR T Cells (AUTO3) for the Treatment of Diffuse Large B Cell LymphomaPHASE1_PHASE2 · TERMINATED · started Sep 5, 2017ClinicalTrials.gov NCT03287817 · fetched Nov 12, 2026
- Expanded Access Program for OOS Obe-celAVAILABLEClinicalTrials.gov NCT06799221 · fetched Nov 12, 2026